Spruce Biosciences, Inc. · NASDAQ:SPRB
Citadel Advisors LLC's stake in Spruce Biosciences, Inc. fell to 1.90% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Citadel Advisors LLC's stake in Spruce Biosciences, Inc. fell to 1.90%, 51,919 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 1.90%
- Shares
- 51,919
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Citadel Advisors LLC | 1.70% | 46,960 |
| Citadel Advisors Holdings LP | 1.70% | 46,960 |
| Citadel GP LLC | 1.70% | 46,960 |
| Citadel Securities LLC | 0.10% | 1,684 |
| Citadel Securities Group LP | 0.20% | 4,959 |
| Citadel Securities GP LLC | 0.20% | 4,959 |
| Kenneth Griffin | 1.90% | 51,919 |
Source
Related
- Spruce Biosciences, Inc.
- Citadel Advisors LLC
- Spruce Biosciences, Inc. shareholders
- Schedule 13G/A · Citadel Advisors LLC · May 15, 2026
- Schedule 13G/A · Citadel Advisors LLC · Feb 17, 2026
- Schedule 13G · Citadel Advisors LLC · Oct 16, 2025
- Schedule 13G · AWM Investment Company, Inc. · Aug 14, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G · Orbimed Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Millennium Management LLC · Aug 4, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026